Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 5 | 2023 | 111 | 1.870 |
Why?
|
| Firearms | 2 | 2023 | 67 | 0.840 |
Why?
|
| Overweight | 2 | 2020 | 119 | 0.830 |
Why?
|
| Thoracic Injuries | 1 | 2020 | 38 | 0.710 |
Why?
|
| Body Mass Index | 2 | 2020 | 771 | 0.700 |
Why?
|
| Injury Severity Score | 5 | 2023 | 143 | 0.650 |
Why?
|
| Trauma Centers | 5 | 2023 | 144 | 0.640 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 99 | 0.610 |
Why?
|
| Wounds and Injuries | 3 | 2018 | 257 | 0.550 |
Why?
|
| Abdominal Abscess | 2 | 2023 | 22 | 0.450 |
Why?
|
| Abdominal Cavity | 2 | 2023 | 18 | 0.450 |
Why?
|
| Abdominal Injuries | 2 | 2023 | 46 | 0.440 |
Why?
|
| Physicians | 1 | 2019 | 689 | 0.410 |
Why?
|
| Quality Improvement | 2 | 2017 | 447 | 0.400 |
Why?
|
| Wounds, Penetrating | 2 | 2021 | 57 | 0.380 |
Why?
|
| Thinness | 2 | 2020 | 44 | 0.360 |
Why?
|
| Benchmarking | 2 | 2017 | 79 | 0.350 |
Why?
|
| Hospital Mortality | 2 | 2017 | 386 | 0.260 |
Why?
|
| Glasgow Coma Scale | 2 | 2021 | 73 | 0.250 |
Why?
|
| Retrospective Studies | 8 | 2023 | 9003 | 0.210 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2012 | 15 | 0.210 |
Why?
|
| Wounds, Gunshot | 1 | 2023 | 90 | 0.190 |
Why?
|
| Shock | 1 | 2021 | 44 | 0.190 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 111 | 0.190 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 262 | 0.180 |
Why?
|
| Respiration Disorders | 1 | 2020 | 41 | 0.170 |
Why?
|
| Politics | 1 | 2019 | 52 | 0.170 |
Why?
|
| Compartment Syndromes | 1 | 2018 | 13 | 0.160 |
Why?
|
| Carcinoma | 1 | 2012 | 443 | 0.160 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2006 | 299 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 159 | 0.150 |
Why?
|
| Physical Examination | 1 | 2018 | 148 | 0.150 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8203 | 0.150 |
Why?
|
| Humans | 15 | 2023 | 89073 | 0.140 |
Why?
|
| Risk Factors | 3 | 2023 | 5466 | 0.140 |
Why?
|
| Comorbidity | 1 | 2020 | 948 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2020 | 850 | 0.140 |
Why?
|
| Adult | 6 | 2023 | 26508 | 0.120 |
Why?
|
| Registries | 3 | 2021 | 778 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 262 | 0.110 |
Why?
|
| Fetal Blood | 1 | 2004 | 93 | 0.110 |
Why?
|
| Obesity | 1 | 2020 | 966 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2009 | 61 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 269 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2005 | 161 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6777 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 207 | 0.110 |
Why?
|
| Young Adult | 2 | 2021 | 6289 | 0.100 |
Why?
|
| Length of Stay | 2 | 2021 | 732 | 0.100 |
Why?
|
| Male | 6 | 2021 | 42254 | 0.090 |
Why?
|
| United States | 2 | 2023 | 6957 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2021 | 2291 | 0.090 |
Why?
|
| Middle Aged | 4 | 2021 | 25865 | 0.090 |
Why?
|
| Aged | 3 | 2021 | 19078 | 0.090 |
Why?
|
| Female | 6 | 2021 | 46014 | 0.080 |
Why?
|
| Liver | 2 | 2023 | 1205 | 0.080 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 36 | 0.070 |
Why?
|
| Age Factors | 2 | 2021 | 1867 | 0.070 |
Why?
|
| Bone Marrow Purging | 1 | 2006 | 7 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 373 | 0.070 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2006 | 64 | 0.060 |
Why?
|
| Cyclophosphamide | 1 | 2006 | 299 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 168 | 0.060 |
Why?
|
| Pulse | 1 | 2014 | 17 | 0.060 |
Why?
|
| Abbreviated Injury Scale | 1 | 2014 | 11 | 0.060 |
Why?
|
| Survival Rate | 1 | 2017 | 1889 | 0.060 |
Why?
|
| Abdomen | 1 | 2023 | 122 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2012 | 168 | 0.050 |
Why?
|
| Violence | 1 | 2023 | 153 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2023 | 988 | 0.050 |
Why?
|
| Machine Learning | 1 | 2023 | 257 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2006 | 261 | 0.050 |
Why?
|
| Adolescent | 2 | 2021 | 9237 | 0.040 |
Why?
|
| Antigens, CD34 | 2 | 2006 | 159 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2014 | 899 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2006 | 788 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 781 | 0.040 |
Why?
|
| Fasciotomy | 1 | 2018 | 17 | 0.040 |
Why?
|
| Chicago | 1 | 2023 | 1423 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 1063 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1796 | 0.040 |
Why?
|
| Transplantation, Autologous | 2 | 2009 | 343 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2005 | 9 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2752 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2006 | 2880 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2005 | 57 | 0.030 |
Why?
|
| Karyotyping | 1 | 2005 | 253 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 155 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 3147 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 195 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3717 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2005 | 217 | 0.030 |
Why?
|
| Culture Media | 1 | 2004 | 147 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2005 | 234 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2004 | 173 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 466 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1043 | 0.020 |
Why?
|
| Peptides | 1 | 2005 | 647 | 0.020 |
Why?
|
| Child | 1 | 2021 | 7149 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 2009 | 28 | 0.020 |
Why?
|
| Balloon Occlusion | 1 | 2009 | 29 | 0.020 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2009 | 58 | 0.020 |
Why?
|
| Myocarditis | 1 | 2009 | 51 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 328 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2009 | 105 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 252 | 0.020 |
Why?
|
| Swine | 1 | 2009 | 581 | 0.020 |
Why?
|
| Mice | 2 | 2006 | 11742 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 271 | 0.020 |
Why?
|
| Animals | 3 | 2009 | 27324 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 329 | 0.020 |
Why?
|
| Time Factors | 1 | 2005 | 5320 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 802 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2009 | 1715 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2006 | 370 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 1755 | 0.010 |
Why?
|
| Heart Failure | 1 | 2009 | 1180 | 0.010 |
Why?
|